The Latest News on Alzheimer's Disease   | Memory Test

New Study Using Neuropsychological Testing Shows Signs of Cognitive Impairment Preceed
Alzheimer's Disease 

MONDAY, Aug. 1 (HealthDay News) -- Years before a person is diagnosed with Alzheimer's disease, there are early warning signs in the form of cognitive problems, new research suggests.

Swedish researchers at the Karolinska Institute, Stockholm, reviewed the findings of 47 studies published between 1985 and 2003. The studies included over 1,200 people with preclinical Alzheimer's disease who later developed the degenerative brain disease and over 9,000 people who did not develop the disease.

Their analysis revealed that people with preclinical Alzheimer's show warning signs in a number of cognitive areas years before they're officially diagnosed with the disease. These signs included marked deficits in global cognitive ability, episodic memory, perceptual speed, and executive functioning. They also display smaller deficits in verbal ability, visuospatial skill and attention. There was no sign of preclinical problems in terms of primary memory.

The review authors noted that many of the cognitive deficits observed in people with preclinical Alzheimer's disease are quite similar to signs of normal aging. However, these problems are more apparent in people who are later diagnosed with Alzheimer's.

The findings appear in the July issue of the journal Neuropsychology.




Alzheimer's

Is there any treatment?

There is no cure for AD and no way to slow the progression of the disease. For some people in the early or middle stages of AD, medication such as tacrine (Cognex) may alleviate some cognitive symptoms. Donepezil (Aricept), rivastigmine (Exelon), and galantamine (Reminyl) may keep some symptoms from becoming worse for a limited time. A fifth drug, memantine (Namenda), was recently approved for use in the United States. Combining memantine with other AD drugs may be more effective than any single therapy. One controlled clinical trial found that patients receiving donepezil plus memantine had better cognition and other functions than patients receiving donepezil alone. Also, other medications may help control behavioral symptoms such as sleeplessness, agitation, wandering, anxiety, and depression. Prevention, through lifestyle changes and mental and physcial exercise, represents one of the best ways to reduce the likelihood of getting the disease, coupled with regular, systematic monitoring.  

What is the prognosis?

AD is a progressive disease, but its course can vary from 5 to 20 years. The most common cause of death in AD patients is infection.  As the population ages and other diseases are brought under control - Alzheimer's becomes a major risk.

What research is being done?


Scientists are currently studying or testing different types of drugs and other substances to determine if they can stop AD progression, including nonsteroidal anti-inflammatory drugs (NSAIDS), statins (such as those used for lowering cholesterol), folic acid, gingko biloba, huperzine, and vitamins E, B6, and B12. Studies in basic science are also exploring the potential of vaccines. Regular  'screenings' are being advocated by some - with the U.S. House of Representatives recently passing a bill in support of early memory check-ups.  All advocate a regimen of physical exercise and mental exercise. If you start an exercise regimen or just walking use MemCheck to track your progress.

Read testimonials from scientists and physicians on MemCheck.
  Give Memory For Life as a Gift for a loved one. Actions taken today help tomorrow.
Give the Gift of TV - Cognitive Labs and Microsoft are partnering on a special offer.

Source: NIH and Cognitive Advisors. For a qualified medical opinion or diagnosis, please see your healthcare provider.  

Famous People and Alzheimers: former President Ronald Reagan, Grambling University football coach Eddie Robinson, actor Charlton Heston, actor James Doohan.   
                                                                                   
Buy now - only 18 cents per day!              
Buy now
18 cents per day/$69.95 year

  Already a Member? Log in                
Easy monthly payment - $9.95 per month-Go!
Buy now
33 cents per day/$9.95 month - less than a newspaper or coffee.
Read about us in